Literature DB >> 3353443

Effect of chronic dietary treatment with L-tryptophan on the development of renal hypertension in rats.

M J Fregly1, O E Lockley, J R Cade.   

Abstract

Chronic dietary administration of L-tryptophan (2.5 and 5.0 g/100 g food) to rats provided significant protection against the development of hypertension induced by bilateral encapsulation of the kidneys with latex envelopes. Lower doses of tryptophan (0.5 and 1.0 g/100 g food) attenuated the rate of elevation of blood pressure, but failed to maintain systolic blood pressures at levels significantly below that of untreated renal hypertensive controls. The body weight of the rats was not affected significantly by treatment with any dose of tryptophan used. Chronic treatment with tryptophan also protected against the reduced urinary concentrating ability during a 24-hour dehydration that characteristically accompanies renal encapsulation. A modest (5-8%) effect of treatment to reduce cardiac hypertrophy was also observed. The mechanism of the antihypertensive effect of tryptophan is not revealed by these studies although they rule out the possibilities that reduction in sodium intake and/or reduction in body weight may be important factors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3353443     DOI: 10.1159/000138364

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  3 in total

Review 1.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

2.  Effect of tryptophan and 5-hydroxytryptophan on the blood pressure of patients with mild to moderate hypertension.

Authors:  J R Cade; M J Fregly; M Privette
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

Review 3.  Developmental Programming and Reprogramming of Hypertension and Kidney Disease: Impact of Tryptophan Metabolism.

Authors:  Chien-Ning Hsu; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.